Abstract
This study is trying to learn and understand if the chemotherapy drug called carboplatin
works as well as the standard therapy. The standard therapy for Low Grade Glioma (LGG) in
children and young adults is using a combination of carboplatin and vincristine. Studies in
children have shown that the use of carboplatin alone has promise of being just as effective
for treating LGG as standard therapy. Additionally, this study will try to understand if
treatment with carboplatin alone is associated with an improved quality of life for LGG
patients and their families.
